Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995-2004

Medical Care

Volumn 46, Issue 1, 2008, Pages 70-77

  Rasmussen, Søren ^a,e   Abildstrom, Steen Z ^a   Rasmussen, Jeppe N ^a   Gislason, Gunnar H ^a   Schramm, Tina K ^b   Folke, Fredrik ^b   Køber, Lars ^c   Torp Pedersen, Christian ^c   Madsen, Mette ^a,d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Bispebjerg University Hospital   (Norway)

^c Rigshospitalet

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Acute myocardial infarction; Hierarchical regression; Hospital quality; Performance measurement; Quality measurement; Secondary prevention; Temporal trends

Indexed keywords

CARDIOVASCULAR AGENT;

ADULT; AGED; ARTICLE; DRUG UTILIZATION; FEMALE; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITAL MANAGEMENT; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATIENT CARE; PREVENTIVE HEALTH SERVICE; SOCIOECONOMICS; STATISTICS; TIME;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CONTINUITY OF PATIENT CARE; DRUG UTILIZATION; FEMALE; HOSPITAL ADMINISTRATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; PREVENTIVE HEALTH SERVICES; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 37649007410     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3181484952     Document Type: Article

References (23)

1. Bradley EH, Herrin J, Elbel B, et al. Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA. 2006;296:72-78.
2. Granger CB, Steg PG, Peterson E, et al. Medication performance measures and mortality following acute coronary syndromes. Am J Med. 2005;118:858-865.
3. Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA. 2006;295:1912-1920.
4. Bradley EH, Herrin J, Mattera JA, et al. Hospital-level performance improvement: beta-blocker use after acute myocardial infarction. Med Care. 2004;42:591-599.
5. Rasmussen JN, Gislason GH, Abildstrom SZ, et al. Statin use after acute myocardial infarction: a nationwide study in Denmark. Br J Clin Pharmacol. 2005;60:150-158.
6. Gislason GH, Abildstrom SZ, Rasmussen JN, et al. Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. Scand Cardiovasc J. 2005;39:42-49.
7. Tu JV, Austin PC, Walld R, et al. Development and validation of the Ontario acute myocardial infarction mortality prediction rules. J Am Coll Cardiol. 2001;37:992-997.
8. Rasmussen S, Zwisler AD, Abildstrom SZ, et al. Hospital variation in mortality after first acute myocardial infarction in Denmark from 1995 to 2002: lower short-term and 1-year mortality in high-volume and specialized hospitals. Med Care. 2005;43:970-978.
9. Merlo J, Chaix B, Ohlsson H, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006;60:290-297.
10. Rasmussen S. Hierarchical modelling of small area and hospital variation in short-term prognosis after acute myocardial infarction. A longitudinal study of 35- to 74-year-old men in Denmark between 1978 and 1997. Stat Med. 2004;23:2599-2621.
11. Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115-121.
12. Krumholz HM, Radford MJ, Wang Y, et al. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998;280:623-629.
13. Kosseim M, Mayo NE, Scott S, et al. Ranking hospitals according to acute myocardial infarction mortality: should transfers be included? Med Care. 2006;44:664-670.
14. Packer M, Bristow MR, Cohn JN, et al. The effect of Carvedilol onmorbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349-1355.
15. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489-497.
16. Dargie HJ. Effect of Carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385-1390.
17. Birkhead JS, Weston C, Lowe D. Impact of specialty of admitting physician and type of hospital on care and outcome for myocardial infarction in England and Wales during 2004-5: observational study. BMJ. 2006;332:1306-1311.
18. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
19. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623-1630.
20. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153.
21. Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, doubleblind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782-788.
22. Bradley EH, Herrin J, Mattera JA, et al. Quality improvement efforts and hospital performance: rates of beta-blocker prescription after acute myocardial infarction. Med Care. 2005;43:282-292.
23. Jollis JG, DeLong ER, Peterson ED, et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med. 1996;335:1880-1887.